HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.

Abstract
We previously reported that Salmonella typhimurium SR-11 mutants with deletion mutations in the genes encoding adenylate cyclase (cya) and the cAMP receptor protein (crp) are avirulent and protective in mice. Salmonella typhimurium UK-1 is highly virulent for chicks (oral LD50 of 3x10(3) CFU) and mice (oral LD50 of 8.5x10(3) CFU) and is capable of lethal infections in pigs, calves and horses. We postulated that attenuated derivatives of this lethal strain would probably induce a higher level of protective immunity than achieved with attenuated derivatives of less virulent S. typhimurium strains such as SR11. To test this hypothesis, we have constructed S. typhimurium UK-1 Deltacya-12Deltacrp-11 mutant strain chi3985 and its virulence plasmid cured derivative chi4095 to investigate their avirulence and immunogenicity in mice. We found that the mutants are avirulent and able to induce protective immune responses in BALB/c mice. These mutant strains retained wild-type ability to colonize the gut associated lymphoid tissue but reach and persist in spleen and liver at a significantly lower level than the wild-type parent strain. Mice survived oral infection with >1x10(9) CFU of chi3985 (the equivalent to 10(5) 50% lethal doses of wild-type S. typhimurium UK-1) and were fully protected against challenge with 10(5)times the LD50 of the wild-type parent. Immunized mice developed a high level of serum IgG titre to Salmonella LPS and delayed-type hypersensitivity (DTH) response to S. typhimurium outer membrane proteins. Compared to the virulence plasmid-containing strain chi3985, the virulence plasmid cured DeltacyaDeltacrp mutant strain chi4095 was more attenuated and less protective, as some mice immunized with chi4095 died when challenged with the wild-type UK-1 strain. This work demonstrates that S. typhimurium UK-1 Deltacrp Deltacya mutant strain may be a potential live vaccine to induce protective immunity against Salmonella infection or to deliver foreign antigens to the immune system.
AuthorsX Zhang, S M Kelly, W Bollen, R Curtiss 3rd
JournalMicrobial pathogenesis (Microb Pathog) Vol. 26 Issue 3 Pg. 121-30 (Mar 1999) ISSN: 0882-4010 [Print] England
PMID10089152 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 1999 Academic Press.
Chemical References
  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Cyclic AMP Receptor Protein
  • Vaccines, Attenuated
  • Adenylyl Cyclases
Topics
  • Adenylyl Cyclases (genetics)
  • Administration, Oral
  • Animals
  • Antibodies, Bacterial (blood)
  • Antibody Specificity
  • Bacterial Vaccines (administration & dosage, immunology)
  • Cyclic AMP Receptor Protein (genetics)
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Mutation
  • Plasmids (genetics, immunology)
  • Salmonella typhimurium (genetics, immunology, pathogenicity)
  • Splenomegaly (microbiology)
  • Time Factors
  • Vaccines, Attenuated (administration & dosage, immunology)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: